...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis
【24h】

Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis

机译:Syndecan-1和基质普康肝硫酸盐蛋白多糖:血浆细胞生物学和骨髓瘤发病机制的关键主导剂

获取原文
获取原文并翻译 | 示例

摘要

Plasma cells no longer express a B-cell antigen receptor and are hence deprived of signals crucial for survival throughout B-cell development. Instead, normal plasma cells, aswell as their malignantmyelomacounterparts, heavily rely on communication with the bone marrow (BM) microenvironment for survival. The plasma cell heparan sulfate proteoglycan (HSPG) syndecan-1 (CD138) and HSPGs in the BM microenvironment act as master regulators of this communication by co-opting specific growth and survival factors from the BM niche. This designates syndecan-1/HSPGs and their synthesis machinery as potential treatment targets in multiple myeloma.
机译:浆细胞不再表达B细胞抗原受体,因此在整个B细胞发育过程中失去了对生存至关重要的信号。取而代之的是,正常浆细胞及其恶性骨髓基质细胞严重依赖与骨髓(BM)微环境的通讯来生存。BM微环境中的浆细胞硫酸乙酰肝素蛋白多糖(HSPG)syndecan-1(CD138)和HSPG通过从BM生态位中选择特定的生长和存活因子,充当这种通讯的主要调节器。这将syndecan-1/HSPGs及其合成机制指定为多发性骨髓瘤的潜在治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号